These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10206825)

  • 1. Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.
    Butterworth RF
    Metab Brain Dis; 1998 Dec; 13(4):337-49. PubMed ID: 10206825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.
    Butterworth RF
    Metab Brain Dis; 2001 Jun; 16(1-2):55-65. PubMed ID: 11726089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms.
    Butterworth RF
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S11-6. PubMed ID: 15025246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The astrocytic ("peripheral-type") benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy.
    Butterworth RF
    Neurochem Int; 2000 Apr; 36(4-5):411-6. PubMed ID: 10733008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of cirrhosis III. Hepatic encephalopathy.
    Butterworth RF
    J Hepatol; 2000; 32(1 Suppl):171-80. PubMed ID: 10728803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic encephalopathy: An update of pathophysiologic mechanisms.
    Hazell AS; Butterworth RF
    Proc Soc Exp Biol Med; 1999 Nov; 222(2):99-112. PubMed ID: 10564534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal-systemic encephalopathy: a disorder of neuron-astrocytic metabolic trafficking.
    Butterworth RF
    Dev Neurosci; 1993; 15(3-5):313-9. PubMed ID: 7805584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current theories on the pathogenesis of hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Proc Soc Exp Biol Med; 1994 Sep; 206(4):329-44. PubMed ID: 7915420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
    Albrecht J; Jones EA
    J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosteroids and hepatic encephalopathy: an update on possible pathophysiologic mechanisms.
    Ahboucha S
    Curr Mol Pharmacol; 2011 Jan; 4(1):1-13. PubMed ID: 20825363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "peripheral-type" benzodiazepine (omega 3) receptor in hyperammonemic disorders.
    Desjardins P; Butterworth RF
    Neurochem Int; 2002; 41(2-3):109-14. PubMed ID: 12020611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Spectroscopy for Evaluating Portal-Systemic Encephalopathy in Patients with Chronic Hepatic Schistosomiasis Japonicum.
    Li Y; Mei L; Qiang J; Ju S; Zhao S
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005232. PubMed ID: 27977668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep disorders and portal-systemic encephalopathy following transjugular intrahepatic portosystemic stent shunt in patients with liver cirrhosis. Relation to plasma tryptophan.
    Wiltfang J; Nolte W; von Heppe J; Bahn E; Pilz J; Hajak G; Rüther E; Ramadori G
    Adv Exp Med Biol; 1999; 467():169-76. PubMed ID: 10721053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portacaval anastomosis causes selective alterations of peripheral-type benzodiazepine receptor expression in rat brain and peripheral tissues.
    Desjardins P; Bandeira P; Rao VL; Butterworth RF
    Neurochem Int; 1999 Oct; 35(4):293-9. PubMed ID: 10482349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities.
    Butterworth RF
    J Steroid Biochem Mol Biol; 2016 Jun; 160():94-7. PubMed ID: 26589093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular aspects of hepatic encephalopathy].
    Márquez-Aguirre AL; Canales-Aguirre AA; Gómez-Pinedo U; Gálvez-Gastélum FJ
    Neurologia; 2010 May; 25(4):239-47. PubMed ID: 20609302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinemia in portal systemic encephalopathy.
    McClain CJ; Kromhout JP; Elson MK; Van Thiel DH
    Dig Dis Sci; 1981 Apr; 26(4):353-7. PubMed ID: 7238264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Peripheral-type" (mitochondrial) benzodiazepine receptors in hepatic encephalopathy.
    Lavoie J; Butterworth RF
    Alcohol Alcohol Suppl; 1993; 2():181-5. PubMed ID: 7748297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Neurochem Int; 2008; 52(4-5):575-87. PubMed ID: 17610999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothermia attenuates oxidative/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure.
    Jiang W; Desjardins P; Butterworth RF
    Neurochem Int; 2009; 55(1-3):124-8. PubMed ID: 19428816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.